Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Preventing Adverse Events in Neonates (SEPREVEN): a Stepped-wedge Randomised Controlled Trial to Reduce Adverse Event Rates in the NICU

NCT02598609 is registered in ClinicalTrials.gov with Dr Caeymaex Laurence as lead sponsor.

NCT NCT02598609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02598609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Preventing Adverse Events in Neonates (SEPREVEN): a Stepped-wedge Randomised Controlled Trial to Reduce Adverse Event Rates in the NICU
Lead sponsor
Dr Caeymaex Laurence
Phase
Not applicable
Overall status
Completed
Start date
November 23, 2015
Completion date
December 8, 2020
Enrollment
8,000 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

catheter-related bloodstream infection (crbsi) nos, extravasation injury, immature newborn, intensive care units, neonatal, intubation complication, iv catheter nos deep venous thrombosis, medication administered in error, misadventures to patients during surgical and medical care, nasal injury, nosocomial pneumonia, quality of healthcare, skin lesion, ventilator adverse event